SEC Form 4 · accession 0000899243-17-018472
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark S Shearman
Officer — Chief Scientific Officer
Period of report
Jul 17, 2017
Accepted (ET)
Jul 18, 2017 · 8:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.90 | Jul 17, 2017 | A | 50,000 | A | — | Jul 17, 2027 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The option becomes exercisable in equal monthly installments over four years from the date of grant.